Tissue Regenix, the Listed Leeds-based med tech business, has appointed an interim Non-Executive Chair to replace Executive Chair John Samuel.
Jonathan Glenn, the company’s current Non-Executive Director, will now serve as Non-Executive Chair with Mr Samuel stopping down from both the business and the board after twelve years with the company.
Mr Glenn most recently served as CEO of Consort Medical from 2007 until its recent acquisition by Recipharm AB, and has strong operational experience in the sector.
The Board said it “will review the position of Chair in due course”.
“Jonathan brings with him a deep understanding of the healthcare industry and experience in leading companies through successful growth phases,” said Randeep Grewal, Chair of the Nomination Committee.
“Jonathan’s knowledge and leadership will be increasingly valuable as we look to secure the next stage of our commercial development.”